期刊文献+

大黄酸对糖尿病大鼠肾脏系膜细胞炎症因子的调控 被引量:6

Effects of Rheic Acid on Inflammatory Cytokines in Rats with Diabetic Nephropathy
下载PDF
导出
摘要 目的观察大黄酸(Rheic acid)对高糖(30mmol/L)诱导的大鼠肾脏系膜细胞(MsC)转化生长因子β1(TGF-β1)及单核细胞趋化因子(MCP-1)表达的影响,探讨其肾脏保护的可能机制。方法大黄酸作用于高糖诱导的MsC,运用MTS检测细胞存活率,ELISA法测定细胞上清TGF-β1、MCP-1含量,RT-PCR法检测MCP-1、TGF-β1 m RNA表达量。结果与模型组(高糖30mmol/L)比较,大黄酸(62.5、125、250μg/mL)干预组Ms C细胞存活率明显上升(59%、75%、84%比53%,P<0.05)。高糖(30mmol/L)作用于Ms C细胞后,TGF-β1、MCP-1表达被激活,与正常组比较,差异有统计学意义(P<0.05)。大黄酸(62.5、125、250μg/mL)干预后,TGF-β1及MCP-1活性均被抑制,与模型组比较,差异均有统计学意义(P<0.05)。结论大黄酸可以通过调控MCP-1和TGF-β1表达,从而减少高糖诱导的MsC炎症反应。 Objective To investigate the effect of Rheic acid on the expression of transforming growth factor-βl(TGF-β1) and monocyte chemoattractant protein-1(MCP-1)on mesangial cells of high glucose(30mmol/L) induced diabetic rats and the mechanism under its renal protection. Methods Mesangial cells from diabetic rats induced by high glucose was treated with Rheic acid, then the cell survival rate was detected by using MTS method, the level of TGF-β1 and MCP-1in cell supernatant was determined with ELISA, and the m RNA transcription of MCP-1 and TGF-β1 was assessed by RT-PCR. Results Compared with model group(high glucose group), the cell survival rate in Rheic acid groups(62.5, 125, 250μg/mL) increased(84%, 75%, 59% vs 53%, all P〈0.05). The expression of TGF-β1 and MCP-1 in high glucose-induced mesangial cells was increased compared with healthy mesangial cells(P〈0.05), but the increase was significantly inhibited after the treatment of Rheic acid(62.5, 125,250μg/mL, all P〈0.05). Conclusion Rheic acid can alleviatehigh glucose-inducedinflammatoryresponse of mesangial cells by regulating the expression of TGF-β1 and MCP-1.
出处 《浙江中西医结合杂志》 2016年第8期714-716,F0002,共4页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省中医药科技计划项目(No.2012ZB059) 国家自然科学基金项目(No.81202709)
关键词 大鼠 肾脏系膜细胞 大黄酸 TGF-Β1 MCP-1 rats mesangial cells Rheic acid TGF-β1 MCP-1
  • 相关文献

参考文献9

  • 1Basevi V, Di Mario S, Morciano C, et al.Comment on : Ameri- can Diabetes Association.Standards of medical care in dia- betes-2011 [J ].Diabetes Care, 2011,34( 8 ) : 1887.
  • 2Fukui M,Tanaka M,Asano M,et al.Serum allograft inflam- Inatory factor-1 is a novel marker for diabetic nephropathy [Jl.Diabetes Res Clin Praet,2012,97( 1 ) : 146-150.
  • 3胡江,缪菁,段淑芳,王亚丽,李能娟,邹玉婷.大黄酸对2型糖尿病模型大鼠的保护作用[J].中国药房,2014,25(23):2113-2116. 被引量:14
  • 4Zuo LI,Du Y,Lu M,et al.Atorvastatin inhibits hypergly- cemia-induced expression of osteopontin in the diabetic rat kidney via the p38 MAPK pathway[J l.Mol Biol Rep, 2014, 41 (4) : 2551-2558.
  • 5Tossidou I 1, Starker G, Kruger J, et al.PKC-alpha modulates TGF-beta signaling and impairs podoeyte surviva[J].Cell Physiol Biochem, 2009,24( 5-6 ) : 627-634.
  • 6Tian C,Jin X,Ye X,et al.Long term intake of 0.1% ethanol decreases serum adiponectin by suppressing PPAR~I ex- pression via p38 MAPK pathway IJ~.Food Chem Toxicol, 2014,9( 65 ) : 329-334.
  • 7Nicholas SB,Liu J, Kim J, et al.Critical role for osteopontin in diabetic nephropathy [ J 3.Kidney International, 2010,4 (77) : 588-600.
  • 8TumLin JA,Galphin CM,Rovin BH.Advanced diabetic ne- phropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on pro- teinuria,progression of CKD,and urinary levels of VEGF and MCP- 1 [ J l.Diabetes Res, 2013,9 ( 12 ) : 489869.
  • 9Chen J,Guo Y,Zeng W,et al.ER stress triggers MCP-1 ex- pression through SET7/9-induced histone methylation in the kidneys of db/db miee[J].Am J Physiol Renal Physiol, 2014,4( 15 ) :916-925.

二级参考文献19

  • 1Schrijivers BF, De Vriese AS. Novel insights in the traeat- ment of diabetic nephropathy[J]. Acta Clin Belg, 2007,62 (5):278.
  • 2Xu Y, Wang L, He J, et al. Prevalence and control of dia- betes in Chinese adults[J]. ,lAMA, 2013,310 (9) : 948.
  • 3Sarafidis PA. Thiazolidinediones and diabetic nephropathy: need for a closer examination[J]. J Cardiometab Syndr, 2007,2(4) : 279.
  • 4Pistrosch E, Herbrig K, Kindel B, et al. Rosigilitazone improves glomerular hyperfiltration, renal endothelial dystrunction, and microalbuminuria of incipient diabetic nephropathy in patients[J]. Diabetes, 2005,54 (7) : 2 206.
  • 5Gao Q, Qin-WS, Jia ZH, et al. Rhein improves renal le- sion and ameliorates dyslipidemia in db/db mice with dia- betic nephropathy[J]. Planta Med, 2010,76( 1 ) : 27.
  • 6Gaikwad AB, Gupta J, Tikoo K, et al. Epigenetic chang- es and alteration of Fbnl and Col3A1 gene expression un- der hyperglycaemic and hyperinsulinaemic conditions[J]. Biochem J, 201 0, 432 (2) : 333.
  • 7Gaikwad AB, Viswanad B, Ramarao P, et al. PPAR gam- ma agonists partially restores hyperglycemia induced ag- gravation of vascular dysfunction to angiotensin 11 in tho- racic aorta isolated from rats with insulin resistance[J]. Pharmacol Res, 2007,55 (5) : 400.
  • 8Sheng NP, Hui HZ, Ai XF, et al. Protection ofrhein on IgA nephropathy mediated by inhibition of fibronectin ex- pression in rats[J], lndian J Pharmacol, 2013,45 ( 2 ) : 174.
  • 9Yang J, Zhang D, Li J, et al. Role of PPAR gamma in re- noprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential[J]. Clin Sci (lond) , 2009, 116 (:)::7.
  • 10de Zeeuw D. Albuminuria: a target for treatment of type 2 diabetic nephropathy[J]. Semin Nephrol, 2007, 27 (2) : 172.

共引文献13

同被引文献92

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部